₹29.96 Crores | Listing at BSE, NSE | Thu, Jan 1, 2026 - Fri, Jan 30, 2026
Vineet Laboratories Limited Rights Issue comprises 0.9987 Cr equity shares aggregating to ₹29.96 Cr, offered at an issue price of ₹30 per share with a face value of ₹10 per share.
The record date for determining eligible shareholder is Dec 23, 2025, with the Rights Issue being offered in the entitlement ratio of 13 : 12.
The term of payment is defined as following : The full amount of the Issue Price being Rs.30/- will be payable on application.
The Rights Entitlements are expected to be credited to eligible demat accounts on Feb 2, 2026.
The Rights Issue opens on Jan 1, 2026, and closes on Jan 30, 2026, with renunciation of Rights Entitlements permitted up to Jan 27, 2026.
The deemed date of allotment is Feb 2, 2026, following which the equity shares are expected to be credited to demat accounts on Feb 3, 2026 and listed at the NSE and the BSE on Feb 3, 2026.
Bigshare Services Pvt.Ltd. is the Registrar to the Issue.
Investors are advised to refer to the Vineet Laboratories Limited Letter of Offer for detailed information, including risk factors, issue terms, and procedural details.
Record Date
Tue, Dec 23, 2025
Entitlement Ratio
13 : 12
Open Date
Thu, Jan 1, 2026
Close Date
Fri, Jan 30, 2026
The full amount of the Issue Price being Rs.30/- will be payable on application.
Vineet Laboratories Limited's revenue decreased by 50% and profit after tax (PAT) dropped by 2066% between the financial year ending with March 31, 2025 and March 31, 2024.
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Total Income | 24.86 | 75.00 | 150.59 |
| Profit After Tax | -0.47 | -20.19 | 1.03 |
| NET Worth | 14.22 | 3.30 | 23.49 |
| Reserves and Surplus | 5.00 | -5.92 | 14.27 |
| Amount in ₹ Crore | |||
Vineet Laboratories Limited is a pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients and intermediates. The company supplies products to domestic and international markets, catering to regulated and semi-regulated pharmaceutical segments.
It focuses on quality compliance, process efficiency, and sustainable manufacturing practices. Vineet Laboratories Limited supports pharmaceutical formulators by delivering consistent, high-quality products across therapeutic categories through its manufacturing capabilities.
The company intend to utilize the gross proceeds raised through the Issue for the following objects:
[Dilip Davda] VLL is engaged in the business of manufacturing, and trading of pharma, dyestuff, chemicals, and dealing in medical/surgical devices, etc. It has posted erratic financial performances for the reported periods with losses in the last one and half year with declined top lines. Based on its recent financial data, the RI appears greedily priced. Declining promoters’ holding raise major concern. There is no harm in skipping this pricey and dicey RI. Read detail review...
Vineet Laboratories Rights Issue 2025 got oversubscribed by 1.06 times by the end of the bidding period with total bid quantity received by BSE and NSE of 1,06,24,804 shares. Check Day by Day Subscription Details (Live Status)
| Date | BSE Bid Quantity | NSE Bid Quantity | Total Bid Quantity | Subscription Times |
|---|---|---|---|---|
Jan 30 2026 17:00:00 | 48,54,027 | 57,70,777 | 1,06,24,804 | 1.06x |
Vineet Laboratories Limited
SY.No. 11/A3, Saheb Nagar,
Kurdu Vill, Chintal Kunta,
Eshwaramma Nilayam, L B Nagar,
Hyderabad, 500074
The Vineet Laboratories Rights Issue 2025 opens on Thu, Jan 1, 2026, and closes on Fri, Jan 30, 2026.
Vineet Laboratories Rights Issue 2025 Schedule
| Last Date for credit of Rights Entitlements | Fri, Dec 26, 2025 |
| Last Date for renunciation of Rights Entitlements | Tue, Jan 27, 2026 |
| Issue Opening Date | Thu, Jan 1, 2026 |
| Issue Closing Date | Fri, Jan 30, 2026 |
| Date of Allotment (on or about) | Mon, Feb 2, 2026 |
| Date of Credit (on or about) | Tue, Feb 3, 2026 |
| Date of Listing (on or about) | Tue, Feb 3, 2026 |
You can apply for Vineet Laboratories Rights Issue 2025 in two ways:
Steps to apply for Vineet Laboratories Rights Issue 2025 using Net Banking (ASBA)
Steps to apply for Vineet Laboratories Rights Issue 2025 using Registrar's website (R-WAP)
